cipla s.a.c.

Activity value 91 india Buyer&Supplier,Last transaction date: 2026-03-31 Address: india,mumbai,mumbai central, mumbai 400 008

Bill of lading data

< 1/15 >
  • Trade date 2026/03/31 B/L No. tzda-26-1212151
  • Suppliers cipla s.a.c. Buyers j.d.pharmacy.ltd
  • POLs —— PODs tzda
  • Supply area India Purchas area Tanzania
  • Weight 613kg Amount 68972.2
  • Hs code 300490000000 Product tags hydrochloride,mg ca,rimax,tamsulosin
  • Product description URIMAX 0.4MG CAPSULE (TAMSULOSIN HYDROCHLORIDE 400MCG) Expand
+View All

Partners

Total 3828

Products

Total 1982
  • Products Transactions Per Detail
  • foreign exchange
    8777 17.4% >
  • provision
    6565 13.01% >
  • management
    6551 12.99% >
  • rod
    5941 11.78% >
  • heme
    5919 11.73% >
  • +View All

Hscode rank

Total 1266
  • HSCode Name Transactions Per Detail
  • HS 30049099 15735 31.19% >
  • HS 30043200 4388 8.7% >
  • HS 30049091 2951 5.85% >
  • HS 30049039 2365 4.69% >
  • HS 30049069 2280 4.52% >
  • +View All

Trading Area

Total 185
  • Area Transactions Per Detail
  • united states 30880 13.43% >
  • south africa 16767 7.29% >
  • brazil 11439 4.98% >
  • australia 10463 4.55% >
  • germany 8836 3.84% >
  • +View All

Port statistics

Total 170
  • Port Name Transactions Per Detail
  • sahar air cargo acc inbom4 44862 19.52% >
  • nhava sheva sea innsa1 38545 16.77% >
  • jnpt 21164 9.21% >
  • bombay air 13057 5.68% >
  • jawaharlal nehru (nhava sheva) 8314 3.62% >
  • +View All
cipla s.a.c. is india Buyer&Supplier,  and primarily engages in the import and export business of products such as foreign exchange,provision,management.  According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 229858 international trades,  with its main trading regions covering united states,south africa,brazil etc.  The core products include HS30049099,HS30043200,HS30049091 etc,  often transported via sahar air cargo acc inbom4,port nhava sheva sea innsa1, port jnpt etc,  and its main trading partners are cipla usa inc.,breathefree lanka pvt ltd.,medpro pharmaceutica pvt ltd..  These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.  They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development. They provide reliable support for cross-border trade decision-making.
The trade data displayed on cipla s.a.c. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis. We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.

Reference contact info


Email Hunting Tool

Whatsapp:+8616621075894(9:00 Am-18:00 Pm (SGT))

About us Contact us Advertise Buyer Supplier Company report Industry report

©2010-2026 52wmb.com all rights reserved